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Global Commission for the Certification of Smallpox
Eradication, certify that smallpox has been eradicated
from the world'. It was on the basis of the evidence
provided in the Final Report of the Global Commission,*
which is now in the course of publication by WHO, that
the World Health Assembly, representing 155 countries
of the world, participated in the historic declaration on
8 May 1980.*
*See top footnote on page 173 and the WHO account follow-
ing it; also footnote on page 177.—Ed.
Frank Fenner, Chairman
Global Commission for the Certification of
Smallpox Eradication, World Health Organization;
John Curtin School of Medical Research
The Australian National University
Canberra City, ACT2601
Australia;
formerly Director
Centre for Resource and Environmental Studies
The Australian National University.
Smallpox Eradication: Man's Success in Eliminating a Most Dangerous Disease
Introduction
In Egypt in the year 1160 B.C., King Ramses V died
of an acute disease that was characterized by a disfiguring
rash. The characteristics and distribution of the rash,
which can be seen on the skin of the King's mummified
body preserved in the Cairo Museum, are such that
scientists believe he died of smallpox. This may be the
first physical evidence in the history of medicine that
smallpox was present in North Africa already more than
3,000 years ago.
Severe epidemics of smallpox or smallpox-like diseases
were described in many areas of Africa and Eurasia before
the 15th century. In the 16th century, smallpox invaded
the Americas, and since the 17th century it has been
rampant practically throughout the world.
There had been no known effective control measures
for this disease until Edward Jenner discovered a vaccine
towards the end of the 18th century. This vaccine had
been gradually used in many countries during the 19th
century and the first half of this present century. Inten-
sive vaccination programmes, developed during this
period in North America and Europe, helped to stop
indigenous spread of the disease in these areas, and thus
the concept of eradication gradually emerged, based on
the realization that the disease was maintained only by
person-to-person transmission. Thus, would it not be
possible to eliminate the disease by giving immunity to
all persons through good vaccination programmes? In
1958, the Russian delegation proposed a resolution aimed
at the global eradication of smallpox to the delegations
at the World Health Assembly, who wholeheartedly
adopted such a resolution. However, progress thereafter
was slow because health services in the zones of endemic
smallpox had only limited resources and were unable to
develop systematic vaccination programmes.
In 1967, an intensified global programme for the
eradication of smallpox was started on the basis of an-
other resolution that had been passed at the session of
the World Health Assembly which had been held in 1966.
This identified the difficulties in programme development
due to unavailability of adequate resources in zones with
endemic smallpox, and decided that the global pro-
gramme should receive funding from the WHO budget as
well as voluntary contributions from developed countries.
For the strategy and development of the programme,
there were a few important advances that were identified
during the campaign as outlined in the next three num-
bered sections:
1) Improvement of Vaccine Quality
When the intensified global campaign was organized
in 1967, the World Health Organization (WHO) carried
out an extensive survey to discover whether the vaccine
that was being used in the countries with endemic small-
pox really met WHO standards. Surprisingly, the results
showed that only 15% of the vaccine batches met WHO
standards. This implied that some 85% of the vaccina-
tions that were being administered during the eradication
campaign throughout the world, were giving incomplete
protection. Urgent action had therefore to be taken.
Vaccine samples from all the producers that were
supplying vaccine to the eradication campaign were
henceforth subject to WHO testing, and only batches of
good quality were used. Intensive consultative work
commenced between international experts and producers
in order to improve the method of production, following
which a simple and practical manual of the production
methodology of the vaccine was made available to the
producers by WHO.
By 1970, 80% of the vaccine met WHO standards
and, by 1973, 95%. This improvement in the quality of
the vaccine was the first important contribution to the
successful development of the programme.
2) From Mass Vaccination to the Surveillance-contain-
ment Method
At the beginning of the campaign, systematic coverage
of the population by effective smallpox vaccination was
considered to be the essential method for ultimate
eradication. However, after two years of the campaign, it
was recognized that this method was unrealistic and in-
effective, and for several reasons. First, 100% vaccination
coverage was a very difficult task to achieve in the areas
where the functioning of the health services was ex-
tremely poor, though it was chiefly in these areas that
smallpox was continuing. Secondly, even if 80—90% of
the population was vaccinated, with great effort, the re-
maining non-immunized 10—20% of the population was
sufficient to maintain smallpox transmission—particu-
larly if the areas were densely populated. On the other
hand, epidemiological investigation of smallpox out-
breaks showed that smallpox cases were now usually
occurring only in a limited number of villages, and that
the spread of the disease was much slower than had pre-
viously been believed.
Now the following question arose: the effective and
economical way to stop transmission would be to identify
the villages where cases were occurring and, instead of
carrying out mass vaccination campaigns on a large scale,
conduct quick and small-scale vaccination programmes
to contain the outbreaks in, for example, a particular
village. In fact this method, termed the 'surveillance—
containment method', proved to be more effective than
mass-vaccination programmes in interrupting transmission
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of smallpox in West and Central Africa during 1967 to
1969. The method was rapidly adapted for the eradica-
tion programmes in other regions, such as South America
and the Indian sub-continent.
Despite the important work of MacCallum & McDon-
ald (1957), a recent study on the effect of temperature
and relative humidity on variola (smallpox) virus in crusts
(scabs) collected from patients, indicated that the virus
remains viable in crusts for only a few months in a tropi-
cal climate (Huq, 1976). More important, however, are
the epidemiological findings in many countries in differ-
ent parts of the world, namely that smallpox has long
been eradicated from them and that there has been no
spontaneous recurrence in them unless it was known
that the disease had been imported by the patient from
one of the remaining areas of endemic smallpox. As well
as North America and Europe, such areas include Mada-
gascar (which has been free from smallpox since 1935),
Philippines (free since 1950), Greece (free since 1951),
Thailand (free since 1963), and Ecuador (free since 1965).
3) Mobilization of World Resources
Member States of WHO recognized the urgency and
desirability of completing eradication as soon as possible.
Accordingly international collaboration between small-
pox-endemic and fund-giving countries developed, in ad-
dition to the WHO regular budget—thus promoting cash
donations, the participation of international epidemiolo-
gists, and engendering free supplies of the vaccine.
Forty-six countries, as well as UNEO, UNICEF, UNDRO,
and a few private organizations, contributed to the WHO
Voluntary Fund for Smallpox Eradication or helped on
a bilateral basis, and these donations have totalled
US$111 millions during the last 13 years. More than 700
epidemiologists from 70 countries participated in the
programme as international personnel.
Achievement
When the intensified global programme was started in
1967, there were 33 smallpox-endemic countries, includ-
ing Brazil in South America, countries in Africa south of
the Sahara, and others in South-East Asia (including In-
donesia). Brazil recorded its last case in 1970 and Indo-
nesia in 1971. South-East Asia, which included the small-
pox-endemic countries of Bangladesh, India, and Pakis-
tan, recorded its last cases in 1975, and the last case in
the world occurred in Somalia in October 1977.
Surveillance continued to check 'entire populations'
by house-to-house visits which were carried out at
regular intervals during at least two years after the
national eradication campaigns reported the occurrence
of the last cases in their countries. These procedures
verified that smallpox transmission had in fact been
stopped.
Benefit—cost Analysis
The achievement of eradication means that smallpox
vaccination certificates for international travellers, and
routine smallpox vaccination programmes, are no longer
necessary. In fact, currently 78 countries have stopped
smallpox vaccination programmes and the number is
expected to increase rapidly. All nations have abolished
the requirement for an international certificate of small-
pox vaccination from travellers, except in four instances
—Chad, Democratic Kampuchea, Djibouti, and Mada-
gascar—which still maintain the requirement.
A total of US$313 millions (US$113 millions from
WHO and sources of international assistance, and roughly
US$200 millions from the endemic-smallpox countries
themselves) was spent during the last 13 years of the
campaign. The savings resulting from the termination of
the vaccination programmes are estimated to be US$ 1000
millions per year. Thus an equivalent of three months'
expenditure should have ensured the elimination of this
dread scourge of humanity for all time!
Post-eradication policy
To maintain the permanent status of eradication, a
post-eradication policy has been established and is being
implemented. Two hundred million doses of vaccine will
be reserved in case of an unexpected emergency.* Epi-
demiological surveillance of suspected cases of smallpox,
and research activities on poxviruses (the group to which
the smallpox virus belongs), are continuing. The small-
pox virus is now confined in test tubes in only six labo-
ratories under strict security and constant surveillance.
Isao Arita, Chief
Smallpox Eradication Unit
World Health Organization
Avenue Appia
1211 Geneva 27
Switzerland.
REFERENCES
HUQ, Farida (1976). Effect of temperature and relative humidi-
ty on variola virus in crusts. Bull. Wld tilth Org., 54(6), pp.
710-2.
MacCALLUM, F. O. & McDONALD, J. R. (1957). Survival of
variola virus in raw cotton. Bull Wld Hlth Org., 16(2), pp.
247-54.
•Including the abhorrent conceivability of 'Deliberate release'
as a biological weapon in warfare or 'by an individual or group as
an act of sabotage or terrorism', though 'unless the public health
services had completely broken down, the outbreak that fol-
lowed could be readily contained and the virus then eliminated'
(The Achievement of Global Eradication of Smallpox: Final
Report of the Global Commission for the Certification of Small-
pox Eradication. World Health Organization, Geneva, Switzer-
land, WHO/SE/79.152, 122 pp., illustr. (mimeogr.).—Ed.
Major Conservation Research Centre for China
China and the World Wildlife Fund (WWF) have
announced plans for a multi-million dollar, jointly-
financed major conservation research centre to be built
in the highlands of Sichuan (Szechwan) Province in
southwestern China. Located in one of the main breeding-
grounds of the Giant Panda (Ailuropoda melanoleuca),
in the 200,000-hectares Wolong Nature Reserve, the
centre will concentrate initially on research on the
endangered Giant Panda and its life-support system,
which faces a major potential threat within the next
decade. At a later date, the centre will expand its re-
search to other species of animals and plants.
Plans for the centre, which represents a cooperation
with foreign specialists that in some ways is probably
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